Fred IT Group

Fred IT Group is Australia's leading provider of IT solutions for the pharmacy sector. The company offers a comprehensive suite of software solutions designed to support all aspects of pharmacy practice, including dispensing, medication management, point-of-sale, professional services, and retail management. Fred IT's flagship product, Fred Dispense Plus, is a cutting-edge dispensing solution that streamlines the medication dispensing process, enabling pharmacists to operate more efficiently while enhancing patient safety.

At the core of Fred IT's technology is a commitment to leveraging technological advancements to improve patient outcomes and empower healthcare professionals. The company's solutions are designed to minimize mouse clicks and provide a seamless user experience, ensuring clinicians can make informed clinical decisions and deliver better care. Fred IT's solutions have been widely adopted, with over 2,500 pharmacies across Australia relying on their software.

In 2022, Fred IT Group launched Fred Marketplace, a web-based hub that allows pharmacies to discover and integrate compatible third-party applications and tools. This platform simplifies the process of identifying and implementing complementary software, enabling pharmacies to enhance their offerings, improve business efficiencies, and introduce new services tailored to their customers' needs.

Fred IT Group has played a pivotal role in driving digital transformation within the Australian healthcare sector. In 2020, the company successfully implemented an end-to-end e-Prescription solution, leveraging the Scaled Agile Framework (SAFe) to deliver this critical project ahead of schedule during the Covid-19 pandemic. This achievement solidified Fred IT's position as a leader in the digital pharmacy space and demonstrated its ability to respond rapidly to evolving market demands.

In May 2024, Telstra Health, Australia's largest eHealth business, announced its acquisition of the remaining 50% stake in Fred IT Group, making it a fully-owned subsidiary. This strategic move marks the culmination of a decade-long joint venture partnership between the two companies and presents opportunities for long-term growth and further digitalization of healthcare services across Australia and beyond.